Acta Chimica Sinica ›› 2023, Vol. 81 ›› Issue (11): 1590-1608.DOI: 10.6023/A23070359 Previous Articles     Next Articles

Special Issue: 庆祝《化学学报》创刊90周年合辑

Review

α-手性三级叠氮化合物的不对称催化合成新进展

高杨a, 张学鑫a, 余金生a,*(), 周剑a,b,c,*()   

  1. a 华东师范大学化学与分子工程学院 石油化工分子转化与反应工程全国重点实验室 上海分子治疗与新药创制工程技术研究中心 上海市绿色化学与化工过程绿色化重点实验室 上海 200062
    b 中国科学院上海有机化学研究所 金属有机化学国家重点实验室 上海 200032
    c 海南师范大学 热带药用资源化学教育部重点实验室 海口 571127
  • 投稿日期:2023-07-28 发布日期:2023-09-30
  • 作者简介:

    高杨, 女, 汉族, 1996年出生于甘肃金昌. 2016年9月本科毕业于河西学院, 2019年9月硕士毕业于云南民族大学有机化学专业, 随后加入华东师范大学周剑教授课题组攻读博士学位, 研究方向为有机小分子催化构建α-手性三级叠氮化合物.

    张学鑫, 男, 汉族, 1992年出生于甘肃张掖. 2016年9月本科毕业于河西学院, 2019年9月硕士毕业于云南民族大学有机化学专业, 随后加入华东师范大学周剑教授课题组攻读博士学位, 研究方向为手性有机硅化合物的合成.

    余金生, 华东师范大学化学与分子工程学院教授, 博士生导师. 2011年本科毕业于江西师范大学; 2016年博士毕业于华东师范大学, 导师周剑教授; 2017至2019年获JSPS资助在日本微生物化学研究所从事博士后研究, 导师Masakatsu Shibasaki教授. 2019年2月加入华东师范大学开展研究工作, 主要从事有机氟硅化学和绿色农药创制等研究.

    周剑, 华东师范大学化学与分子工程学院教授, 博士生导师. 本科毕业于四川师范大学; 2004年毕业于中科院上海有机所, 获理学博士学位, 导师唐勇研究员; 先后在日本东京大学Shu Kobayashi和德国马普煤炭研究所Benjamin List课题组从事博士后研究后, 于2008年底加入华东师范大学. 研究兴趣在于立足协同催化的理念, 结合新催化剂和新试剂的设计开发, 发展导向具有手性季碳的药物优势骨架的不对称催化构建新方法.

    庆祝《化学学报》创刊90周年.
  • 基金资助:
    国家自然科学基金(21971067); 国家自然科学基金(22171087); 上海市教育委员会科研创新计划(2023ZKZD37); 上海市科技创新行动计划(20JC1416900); 上海市科技创新行动计划(21N41900500)

Recent Advances in Catalytic Enantioselective Synthesis of α-Chiral Tertiary Azides

Yang Gaoa, Xuexin Zhanga, Jinsheng Yua(), Jian Zhoua,b,c()   

  1. a State Key Laboratory of Molecular & Process Engineering, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, Shanghai Key Laboratory of Green Chemistry and Chemical Processes, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200062
    b State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032
    c Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education, Hainan Normal University, Haikou 571127
  • Received:2023-07-28 Published:2023-09-30
  • Contact: *E-mail: jsyu@chem.ecnu.edu.cn; jzhou@chem.ecnu.edu.cn
  • About author:
    Dedicated to the 90th anniversary of Acta Chimica Sinica.
  • Supported by:
    National Natural Science Foundation of China(21971067); National Natural Science Foundation of China(22171087); Innovation Program of Shanghai Municipal Education Commission(2023ZKZD37); Shanghai Science and Technology Innovation Action Plan(20JC1416900); Shanghai Science and Technology Innovation Action Plan(21N41900500)

α-Chiral azides are widely used in the fields of synthetic chemistry, medicinal chemistry and life science. Owing to α-chiral azides can be used for the diverse synthesis of α-chiral amine derivatives and nitrogen-containing heterocycles, and its azido group is also a pharmacophore, the efficient synthesis of α-chiral azides is highly important for drug discovery and development. Along with the incorporation of chiral quaternary carbon that can increase the three-dimensional stereospecificity of molecules has become an effective strategy to improve the bioactivity and druggability in drug design and development, the development of catalytic asymmetric synthetic methods toward α-chiral tertiary azides featuring aza-quaternary carbon center is highly desirable to facilitate drug research. However, due to the adverse steric effects caused by the structure of azido group that is close to a straight line, and the challenge of distinguishing the substituents with less difference to construct the aza-quaternary carbon stereocenter, the catalytic asymmetric protocols with high enantioselectivity are relatively scarce. This review aims to summarize the advances of the past five years according to the following two strategies: asymmetric functionalizations of C—N3 bond containing compounds and asymmetric azidations involving C—N3 bond forming, as well as discusses the possible reaction mechanism, the advantages and disadvantages of different reactions, which would provide some references and inspiration for researchers engaged in organic synthesis and medicinal chemistry.

Key words: α-chiral tertiary azide, catalytic asymmetric synthesis, sodium azide, trimethylsilyl azide, electrophilic azidation, nucleophilic addition